US campaign group sets up on-line Medicare advice

13 November 2006

The Medicare Rights Center, a US campaigning organization, has set up an on-line advice service for older people and the disabled, to enable them to select the best Medicare Part D prescription drug benefit plan, as well as to find ways of finding additional financial support for drug costs, where necessary.

The MRC has campaigned against the diversity of plan providers, describing the choices as "confusing," as well as echoing Democratic party positions on federal price controls for prescription drugs, the late-enrollment penalty, among others.

Robert Hayes the MRC's president, in a statement, said: "we are making the independent and consumer friendly on-line tools our counsellors use available to everyone who needs them." Mr Hayes added: "we are helping older and disabled americans make the best drug plan choice possible, especially since most people will be locked into their plan for the entire year and they are unreliable and costly."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight